
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Saborni Chakraborty, Joseph C. González, Benjamín L. Sievers, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 635
Open Access | Times Cited: 103
Saborni Chakraborty, Joseph C. González, Benjamín L. Sievers, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 635
Open Access | Times Cited: 103
Showing 1-25 of 103 citing articles:
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19
Vaughn D. Craddock, Aatish Mahajan, Leslie Spikes, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 87
Vaughn D. Craddock, Aatish Mahajan, Leslie Spikes, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 87
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
Andrew Teo, Hao Dong Tan, Thomas Loy, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011223-e1011223
Open Access | Times Cited: 40
Andrew Teo, Hao Dong Tan, Thomas Loy, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011223-e1011223
Open Access | Times Cited: 40
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Sialylation as an Important Regulator of Antibody Function
Ravi Vattepu, Sunny L. Sneed, Robert M. Anthony
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Ravi Vattepu, Sunny L. Sneed, Robert M. Anthony
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 52
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 52
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
Josée Golay, Alain E. Andrea, Irene Cattaneo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Josée Golay, Alain E. Andrea, Irene Cattaneo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity
Manuel M. Vicente, Inês Alves, Joana Gaifem, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 6, pp. 946-957
Open Access | Times Cited: 38
Manuel M. Vicente, Inês Alves, Joana Gaifem, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 6, pp. 946-957
Open Access | Times Cited: 38
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
Benjamin Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Benjamin Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Mechanisms of antibody-dependent enhancement of infectious disease
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 7
Timothy J. Wells, Tyron Esposito, Ian R. Henderson, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 7
Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
Janita J. Oosterhoff, Mads Delbo Larsen, C. Ellen van der Schoot, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 800-814
Open Access | Times Cited: 33
Janita J. Oosterhoff, Mads Delbo Larsen, C. Ellen van der Schoot, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 800-814
Open Access | Times Cited: 33
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 29
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 29
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
Julie Van Coillie, Tamás Pongrácz, Johann Rahmöller, et al.
EBioMedicine (2022) Vol. 87, pp. 104408-104408
Open Access | Times Cited: 28
Julie Van Coillie, Tamás Pongrácz, Johann Rahmöller, et al.
EBioMedicine (2022) Vol. 87, pp. 104408-104408
Open Access | Times Cited: 28
IgG N-glycome changes during the course of severe COVID-19: An observational study
Tea Petrović, Amrita Vijay, Frano Vučković, et al.
EBioMedicine (2022) Vol. 81, pp. 104101-104101
Open Access | Times Cited: 27
Tea Petrović, Amrita Vijay, Frano Vučković, et al.
EBioMedicine (2022) Vol. 81, pp. 104101-104101
Open Access | Times Cited: 27
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
Paulina Kapłonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1161-1172
Open Access | Times Cited: 17
Paulina Kapłonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1161-1172
Open Access | Times Cited: 17
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines
Julie Van Coillie, Tamás Pongrácz, Tonći Šuštić, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107619-107619
Open Access | Times Cited: 16
Julie Van Coillie, Tamás Pongrácz, Tonći Šuštić, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107619-107619
Open Access | Times Cited: 16